FdaApplication
BLA 021148
Identifiers
- fda_app_no: BLA021148
Properties
| Property | Value |
|---|---|
| applicant_name | Novo Nordisk Inc. |
| application_type | BLA |
| approval_date | 2000-06-20 |
Products (11)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NORDITROPIN | SOMATROPIN | 10MG/1.5ML | Injection |
| NORDITROPIN | SOMATROPIN | 15MG/1.5ML | Injection |
| NORDITROPIN | SOMATROPIN | 5MG/1.5ML | Injection |
| NORDITROPIN | SOMATROPIN | 5MG/1.5ML | Injection |
| NORDITROPIN | SOMATROPIN | 15MG/1.5ML | Injection |
| NORDITROPIN | SOMATROPIN | 10MG/1.5ML | Injection |
| NORDITROPIN | SOMATROPIN | 30MG/3ML | Injection |
| NORDITROPIN | SOMATROPIN | 5MG/1.5ML | Injection |
| NORDITROPIN | SOMATROPIN | 30MG/3ML | Injection |
| NORDITROPIN | SOMATROPIN | 10MG/1.5ML | Injection |
| NORDITROPIN | SOMATROPIN | 15MG/1.5ML | Injection |
11 products